OrthoPediatrics Corp Net Change in Cash
OrthoPediatrics Corp (KIDS) reported Net Change in Cash of -$2.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-05
- OrthoPediatrics Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$7.38M.
- OrthoPediatrics Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$10.35M.
- OrthoPediatrics Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$9.46M, a 136.86% decline year-over-year.
- OrthoPediatrics Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $25.68M, a 148.93% increase year-over-year.
- OrthoPediatrics Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$24.16M, a 289.47% decline from fiscal 2024.
- OrthoPediatrics Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $12.75M, a 43.50% decline from fiscal 2023.
- OrthoPediatrics Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $22.57M, a 1449.79% increase from fiscal 2022.
- OrthoPediatrics Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $1.46M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.56M 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | -$7.38M 10-Q · filed 2026-05-01 | |||
| 2025-12-31 | -$24.16M 10-K · filed 2026-03-04 | |||
| 2025-09-30 | -$26.89M 10-Q · filed 2025-10-29 | |||
| 2025-06-30 | $828.00K 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | -$10.35M 10-Q · filed 2026-05-01 | |||
| 2024-12-31 | $12.75M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $20.02M 10-Q · filed 2025-10-29 | |||
| 2024-06-30 | -$2.14M 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | -$9.46M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $22.57M 10-K · filed 2026-03-04 | |||
| 2023-09-30 | $1.77M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $847.00K 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | $25.68M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $1.46M 10-K · filed 2025-03-05 | |||
| 2022-09-30 | $27.87M 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | $29.55M 10-Q · filed 2023-08-01 | |||
| 2022-03-31 | $10.31M 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | -$21.13M 10-K · filed 2024-03-08 | |||
| 2021-09-30 | -$22.43M 10-Q · filed 2022-11-01 | |||
| 2021-06-30 | -$18.20M 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | -$7.34M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$41.90M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $17.71M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | $42.39M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | -$17.09M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $11.34M 10-K · filed 2022-03-03 | |||
| 2019-09-30 | -$40.18M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$38.47M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | -$7.92M 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $18.11M 10-K · filed 2021-03-11 | |||
| 2018-09-30 | -$18.12M 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | -$16.08M 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | -$7.99M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $40.97M 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |